Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, January 2, 2020
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
Tue, December 31, 2019
[ Tue, Dec 31st 2019
] - WOPRAI
[ Tue, Dec 31st 2019
] - WOPRAI
[ Tue, Dec 31st 2019
] - WOPRAI
Mon, December 30, 2019
[ Mon, Dec 30th 2019
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
Fri, December 27, 2019
[ Fri, Dec 27th 2019
] - WOPRAI
Thu, December 26, 2019
[ Thu, Dec 26th 2019
] - WOPRAI
[ Thu, Dec 26th 2019
] - WOPRAI
Steve Scala Maintained (ABBV) at Buy with Increased Target to $98 on, Dec 26th, 2019
Steve Scala of Cowen & Co., Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $90 to $98 on, Dec 26th, 2019.
Steve has made no other calls on ABBV in the last 4 months.
There are 2 other peers that have a rating on ABBV. Out of the 2 peers that are also analyzing ABBV, 0 agree with Steve's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Steve
- Andrew Baum of "Citigroup" Maintained at Strong Buy with Increased Target to $98 on, Wednesday, November 20th, 2019
- Marc Goodman of "UBS" Maintained at Strong Buy with Increased Target to $96 on, Tuesday, November 19th, 2019
